Pending approval, erdafitinib, an investigational, once-daily oral pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor,1…
Press release – No. 11 / 2023 SAVE THE DATE: Zealand Pharma to host Obesity…
NEW YORK–(BUSINESS WIRE)–#bestplacetowork–Great Place To Work® and Fortune magazine have selected Coro as one of…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
HONG KONG, Sep 8, 2023 – (ACN Newswire) – According to the latest Hong Kong…
KUALA LUMPUR, Sep 8, 2023 – (ACN Newswire) – Paessler, the IT monitoring expert, has…
KUALA LUMPUR & TAIPING, Sep 8, 2023 – (ACN Newswire) – SPRITZER’s Automated Storage and…
GUANGZHOU, China, Sept. 07, 2023 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR and…
HONG KONG, Sep 8, 2023 – (ACN Newswire) – Due to Black Rainstorm Warning is…
LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (“Faraday Future”, “FF” or “Company”), a…
COLUMBIA, Md.–(BUSINESS WIRE)–Corporate Office Properties Trust (“COPT” or the “Company”) (NYSE: OFC) announced today that…
Common Stock Listing on National Exchange is Next Planned Significant Milestone FRAMINGHAM, Mass., Sept. 07,…
Toronto, Ontario and New York, New York–(Newsfile Corp. – September 7, 2023) – Sekur Private…
DENVER–(BUSINESS WIRE)–$PLTR–Palantir Technologies Inc. (NYSE: PLTR) today announced its next AIPCon customer conference will be…
Renowned Leader in Healthcare Technology Including AI Joins Esteemed Clinicians and ICU Physicians on Advisory…
Strong Revenues and Steady Growth in Both Diagnostics and Pharma Segments Drive Sustainable Financial Performance…
TOKYO and SEATTLE, Sept. 07, 2023 (GLOBE NEWSWIRE) — Otsuka Pharmaceutical Co., Ltd. (Otsuka) and…
AUSTIN, Texas, Sept. 07, 2023 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company…
Program will feature members of IMUNON executive management along with key opinion leaders in immuno-oncology…
THE WOODLANDS, Texas, Sept. 07, 2023 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today…